Public Health and Prisons: Priorities in the Age of Mass Incarceration

Literature Cited

1. 1.

   2021 House Resolut. 51 Task Force 2022. Medical release from incarceration: a study of compassionate release, parole, and furlough Rep. La. House Represent. Baton Rouge: https://tinyurl.com/yscryxxd
2. 2.

   Ahalt C, Binswanger IA, Steinman M, Tulsky J, Williams BA. 2012. Confined to ignorance: the absence of prisoner information from nationally representative health data sets. J. Gen. Intern. Med. 27:160–66
   [Google Scholar]
3. 3.

   Ahalt C, Bolano M, Wang EA, Williams B. 2015. The state of research funding from the National Institutes of Health for criminal justice health research. Ann. Intern. Med. 162:345–52
   [Google Scholar]
4. 4.

   Ahalt C, Haney C, Ekhaugen K, Williams B. 2020. Role of a US–Norway exchange in placing health and well-being at the center of US prison reform. Am. J. Public Health 110:S27–29
   [Google Scholar]
5. 5.

   Ahalt C, Rothman A, Williams BA. 2017. Examining the role of healthcare professionals in the use of solitary confinement. BMJ 359:j4657
   [Google Scholar]
6. 6.

   Ahalt C, Trestman RL, Rich JD, Greifinger RB, Williams BA. 2013. Paying the price: the pressing need for quality, cost, and outcomes data to improve correctional healthcare for older prisoners. J. Am. Geriatr. Soc. 61:2013–19
   [Google Scholar]
7. 7.

   Alexander M. 2011. The new Jim Crow. Ohio St. J. Crim. Law 9:7–26
   [Google Scholar]
8. 8.

   AMA (Am. Med. Assoc.) 2020. AMA policy recognizes police brutality as product of structural racism Press Release Nov. 17. https://www.ama-assn.org/press-center/press-releases/ama-policy-recognizes-police-brutality-product-structural-racism
9. 9.

   Anthony-North V, Pope LG, Pottinger S, Sederbaum I. 2018. Corrections-based responses to the opioid epidemic: lessons from New York State's Overdose Education and Naloxone Distribution Program Rep. Vera Inst. Justice New York: https://www.vera.org/downloads/publications/corrections-responses-to-opioid-epidemic-new-york-state.pdf
10. 10.

    APHA (Am. Public Health Assoc.) 2021. Advancing public health interventions to address the harms of the carceral system Polic Statement LB20-05, Oct. 24. https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2021/01/14/advancing-public-health-interventions-to-address-the-harms-of-the-carceral-system
11. 11.

    Appelbaum KL, Savageau JA, Trestman RL, Metzner JL, Baillargeon J. 2011. A national survey of self-injurious behavior in American prisons. Psychiatr. Serv. 62:285–90
    [Google Scholar]
12. 12.

    Armstrong AC. 2014. No prisoner left behind: enhancing public transparency of penal institutions. Stanf. Law Polic. Rev. 25:435–76
    [Google Scholar]
13. 13.

    Armstrong AC. 2016. Racial origins of doctrines limiting prisoner protest speech. Howard Law J. 60:221
    [Google Scholar]
14. 14.

    Armstrong AC. 2017. Death row conditions through an environmental justice lens. Ark. Law Rev. 70:203
    [Google Scholar]
15. 15.

    Austin J, Eisen L-B, Cullen J, Frank J. 2016. How many Americans are unnecessarily incarcerated? Rep. Brennan Cent. Justice, NYU Sch. Law New York: https://www.brennancenter.org/sites/default/files/publications/Unnecessarily_Incarcerated_0.pdf
16. 16.

    Bailey ZD, Feldman JM, Bassett MT. 2021. How structural racism works—racist policies as a root cause of US racial health inequities. N. Engl. J. Med. 384:768–73
    [Google Scholar]
17. 17.

    Barker E, Kõlves K, De Leo D. 2014. Management of suicidal and self-harming behaviors in prisons: systematic literature review of evidence-based activities. Arch. Suicide Res. 18:227–40
    [Google Scholar]
18. 18.

    Barnert E, Kwan A, Williams B. 2021. Ten urgent priorities based on lessons learned from more than a half million known COVID-19 cases in US prisons. Am. J. Public Health 111:1099–105
    [Google Scholar]
19. 19.

    Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. 2010. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J. Acquir. Immune Defic. Syndr. 55:S49–55
    [Google Scholar]
20. 20.

    Bedard R, Metzger L, Williams B. 2016. Ageing prisoners: an introduction to geriatric health-care challenges in correctional facilities. Int. Rev. Red Cross 98:917–39
    [Google Scholar]
21. 21.

    Berryessa CM. 2021. A tale of “second chances”: an experimental examination of popular support for early release mechanisms that reconsider long-term prison sentences. J. Exp. Criminol. https://doi.org/10.1007/s11292-021-09466-x
    [Google Scholar]
22. 22.

    Bertsch L, Choinski W, Kempf K, Baldwin J, Clarke H et al. 2020. Time-in-cell 2019: a snapshot of restrictive housing based on a nationwide survey of U.S. prison systems Work. Pap. Yale Law School New Haven, CT: http://dx.doi.org/10.2139/ssrn.3694548
23. 23.

    Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. 2013. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann. Intern. Med. 159:592–600
    [Google Scholar]
24. 24.

    Binswanger IA, Krueger PM, Steiner JF. 2009. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J. Epidemiol. Community Health 63:912–19
    [Google Scholar]
25. 25.

    Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A et al. 2007. Release from prison—a high risk of death for former inmates. N. Engl. J. Med. 356:157–65
    [Google Scholar]
26. 26.

    Brinkley-Rubinstein L, Cloud DH. 2022. Invited perspective: uncovering harmful exposures in carceral environments. Environ. Health Perspect. 130:091305
    [Google Scholar]
27. 27.

    Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A et al. 2017. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int. J. Prison. Health 13:25–31
    [Google Scholar]
28. 28.

    Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N et al. 2018. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release. Drug Alcohol Depend 184:57–63
    [Google Scholar]
29. 29.

    Brinkley-Rubinstein L, Sivaraman J, Rosen DL, Cloud DH, Junker G et al. 2019. Association of restrictive housing during incarceration with mortality after release. JAMA Netw. Open 2:e1912516
    [Google Scholar]
30. 30.

    Brousseau EC, Ahn S, Matteson KA. 2019. Cervical cancer screening access, outcomes, and prevalence of dysplasia in correctional facilities: a systematic review. J. Women's Health 28:1661–69
    [Google Scholar]
31. 31.

    Bustillo Y. 2021. Compassionate release during crises: expanding federal court powers. Yale Law Polic. Rev. 40:223
    [Google Scholar]
32. 32.

    Calif. Correct. Health Care Serv 2021. CCHCS/DHCS care guide: transgender Guide, Calif. Correct. Health Care Serv. Elk Grove: https://cchcs.ca.gov/wp-content/uploads/sites/60/CG/Transgender-CG.pdf
33. 33.

    Carpentier C, Royuela L, Montanari L, Davis P. 2018. The global epidemiology of drug use in prison. See Ref. 84 17–41
34. 34.

    Carson EA, Mueller S, Zeng Z. 2021. Mortality in state and federal prisons, 2001–2018—statistical tables NCJ 255970 US Dep. Justice Washington, DC: https://bjs.ojp.gov/content/pub/pdf/msfp0118st.pdf
    [Google Scholar]
35. 35.

    Chettiar I, Bunting W, Schotter G. 2012. At America's expense: the mass incarceration of the elderly Rep. Am. Civ. Lib. Union (ACLU) New York: https://www.aclu.org/report/americas-expense-mass-incarceration-elderly
    [Google Scholar]
36. 36.

    Cloud DH, Ahalt C, Augustine D, Sears D, Williams B. 2020. Medical isolation and solitary confinement: balancing health and humanity in US jails and prisons during COVID-19. J. Gen. Intern. Med. 35:2738–42
    [Google Scholar]
37. 37.

    Cloud DH, Augustine D, Ahalt C, Haney C, Peterson L et al. 2021. “We just needed to open the door”: a case study of the quest to end solitary confinement in North Dakota. Health Justice 9:28
    [Google Scholar]
38. 38.

    Cloud DH, Bassett MT, Graves J, Fullilove RE, Brinkley-Rubinstein L. 2020. Documenting and addressing the health impacts of carceral systems. Am. J. Public Health 110:S5
    [Google Scholar]
39. 39.

    Cloud DH, Drucker E, Browne A, Parsons J. 2015. Public health and solitary confinement in the United States. Am. J. Public Health 105:18–26
    [Google Scholar]
40. 40.

    Cloud DH, Parsons J, Delany-Brumsey A. 2014. Addressing mass incarceration: a clarion call for public health. Am. J. Public Health 104:389–91
    [Google Scholar]
41. 41.

    Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G et al. 2012. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int. J. Transgenderism 13:165–232
    [Google Scholar]
42. 42.

    Cooper HLF, Cloud DH, Fanucchi LC, Lofwall M, Young AM. 2022. Dismantling war on drugs policies in COVID-19’s aftermath. Am. J. Public Health 112:S24–27
    [Google Scholar]
43. 43.

    COVID Prison Proj 2022. National COVID-19 statistics. COVID Prison Project https://covidprisonproject.com/data/national-overview/
    [Google Scholar]
44. 44.

    D'Hotman D, Pugh J, Douglas T. 2016. The case against forced methadone detox in the US prisons. Public Health Ethics 12:89–93
    [Google Scholar]
45. 45.

    Davis A. 1998. Masked racism: reflections on the prison industrial complex. ColorLines Sept. 10. https://www.colorlines.com/articles/masked-racism-reflections-prison-industrial-complex
    [Google Scholar]
46. 46.

    Davis AY 2001. Race, gender, and prison history: from the convict lease system to the supermax prison. Prison Masculinities D Sabo, TA Kupers, W London pp. 35–45. Philadelphia: Temple Univ. Press
    [Google Scholar]
47. 47.

    Deitch MY. 2020. But who oversees the overseers?: The status of prison and jail oversight in the United States. Am. J. Crim. Law 47:207
    [Google Scholar]
48. 48.

    DiPietro B, Klingenmaier L. 2013. Achieving public health goals through Medicaid expansion: opportunities in criminal justice, homelessness, and behavioral health with the Patient Protection and Affordable Care Act. Am. J. Public Health 103:e25–29
    [Google Scholar]
49. 49.

    Dolan K, Rutter S, Wodak AD. 2003. Prison-based syringe exchange programmes: a review of international research and development. Addiction 98:153–58
    [Google Scholar]
50. 50.

    Duarte C, Cameron DB, Kwan AT, Bertozzi SM, Williams BA, McCoy SI. 2022. COVID-19 outbreak in a state prison: a case study on the implementation of key public health recommendations for containment and prevention. BMC Public Health 22:977
    [Google Scholar]
51. 51.

    Ekaireb R, Ahalt C, Sudore R, Metzger L, Williams B. 2018. “We take care of patients, but we don't advocate for them”: advance care planning in prison or jail. J. Am. Geriatr. Soc. 66:2382–88
    [Google Scholar]
52. 52.

    FAMM (Famil. Against Mandat. Minim.) 2022. Compassionate release. FAMM https://famm.org/our-work/compassionate-release/
    [Google Scholar]
53. 53.

    Fathi DC. 2010. The challenge of prison oversight. Am. Crim. Law Rev. 47:1453–62
    [Google Scholar]
54. 54.

    Fazel S, Cartwright J, Norman-Nott A, Hawton K. 2008. Suicide in prisoners: a systematic review of risk factors. J. Clin. Psychiatry 69:1721–31
    [Google Scholar]
55. 55.

    Fenster A, Schlanger M. 2021. Slamming the courthouse door: 25 years of evidence for repealing the Prison Litigation Reform Act. Prison Policy Initiative April 26. https://www.prisonpolicy.org/reports/PLRA_25.html
    [Google Scholar]
56. 56.

    Frank RG, Glied SA. 2006. Better but Not Well: Mental Health Policy in the United States Since 1950 Baltimore, MD: Johns Hopkins Univ. Press
57. 57.

    Gilmore WR. 2021. Change Everything: Racial Capitalism and the Case for Abolition Chicago: Haymarket Books
58. 58.

    Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE, Fitzgerald TT, Vocci FJ 2017. A randomized clinical trial of buprenorphine for prisoners: findings at 12-months post-release. Drug Alcohol Depend. 172:34–42
    [Google Scholar]
59. 59.

    Goshin LS, Sissoko DRG, Neumann G, Sufrin C, Byrnes L. 2019. Perinatal nurses’ experiences with and knowledge of the care of incarcerated women during pregnancy and the postpartum period. J. Obstetr. Gynecol. Neonatal Nurs. 48:27–36
    [Google Scholar]
60. 60.

    Gottschalk M. 2009. Money and mass incarceration: the bad, the mad, and penal reform. Criminol. Public Polic. 8:97–109
    [Google Scholar]
61. 61.

    Gough E, Kempf MC, Graham L, Manzanero M, Hook EW et al. 2010. HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health 10:777
    [Google Scholar]
62. 62.

    Grant JM, Mottet L, Tanis JE, Harrison J, Herman J, Keisling M. 2011. Injustice at every turn: A report of the national transgender discrimination survey Rep. Natl. Cent. Transgender Equal. Natl. Gay Lesbian Task Force https://transequality.org/sites/default/files/docs/resources/NTDS_Report.pdf
    [Google Scholar]
63. 63.

    Greene M, Ahalt C, Stijacic-Cenzer I, Metzger L, Williams B. 2018. Older adults in jail: high rates and early onset of geriatric conditions. Health Justice 6:3
    [Google Scholar]
64. 64.

    Greenwald G. 2009. Drug decriminalization in Portugal: lessons for creating fair and successful drug policies Cato Inst. White Pap. Ser. Washington, DC: https://www.cato.org/sites/cato.org/files/pubs/pdf/greenwald_whitepaper.pdf
65. 65.

    Greer A, Bonn M, Shane C, Stevens A, Tousenard N, Ritter A. 2022. The details of decriminalization: designing a non-criminal response to the possession of drugs for personal use. Int. J. Drug Policy 102:103605
    [Google Scholar]
66. 66.

    Haggerty KD, Bucerius S. 2020. The proliferating pains of imprisonment. Incarceration 1:2632666320936432
    [Google Scholar]
67. 67.

    Haley M. 2022. Unequal treatment: (in)compassionate release from federal prison in the context of the COVID-19 pandemic and vaccine. Columbia Law Rev. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4106993
    [Google Scholar]
68. 68.

    Haney C. 2012. Prison effects in the era of mass incarceration. Prison J. https://doi.org/10.1177/0032885512448604
    [Google Scholar]
69. 69.

    Haney C, Williams B, Lobel J, Ahalt C, Allen E, Bertsch L 2020. Consensus statement from the Santa Cruz summit on solitary confinement and health. Northwest. Univ. Law Rev. 115:335–59
    [Google Scholar]
70. 70.

    Harcourt BE. 2007. From the asylum to the prison: rethinking the incarceration revolution. Part II: state level analysis Work. Pap. 335: John M. Olin Program Law Econ. Chicago: https://chicagounbound.uchicago.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=1218&context=law_and_economics
71. 71.

    Harvey TD, Busch SH, Lin H-J, Aminawung JA, Puglisi L et al. 2022. Cost savings of a primary care program for individuals recently released from prison: a propensity-matched study. BMC Health Serv. Res. 22:585
    [Google Scholar]
72. 72.

    Hatzenbuehler ML, Keyes K, Hamilton A, Uddin M, Galea S. 2015. The collateral damage of mass incarceration: risk of psychiatric morbidity among nonincarcerated residents of high-incarceration neighborhoods. Am. J. Public Health 105:138–43
    [Google Scholar]
73. 73.

    Hinton E. 2017. From the War on Poverty to the War on Crime: The Making of Mass Incarceration in America Cambridge, MA: Harvard Univ. Press
74. 74.

    Hinton E, Cook D. 2021. The mass criminalization of Black Americans: a historical overview. Annu. Rev. Criminol. 4:261–86
    [Google Scholar]
75. 75.

    Howell BA, Hawks L, Wang EA, Winkelman TNA. 2022. Evaluation of changes in US health insurance coverage for individuals with criminal legal involvement in Medicaid expansion and nonexpansion states, 2010 to 2017. JAMA Health Forum 3:4e220493
    [Google Scholar]
76. 76.

    Hughes CE, Stevens A. 2010. What can we learn from the Portuguese decriminalization of illicit drugs?. Br. J. Criminol. 50:999–1022
    [Google Scholar]
77. 77.

    Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML et al. 2022. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission. Lancet 399:555–604
    [Google Scholar]
78. 78.

    Ivsins A, Boyd J, Beletsky L, McNeil R. 2020. Tackling the overdose crisis: the role of safe supply. Int. J. Drug Policy 80:102769
    [Google Scholar]
79. 79.

    Jewkes Y, Jordan M, Wright S, Bendelow G. 2019. Designing ‘healthy’ prisons for women: incorporating trauma-informed care and practice (TICP) into prison planning and design. Int. J. Environ. Res. Public Health 16:203818
    [Google Scholar]
80. 80.

    Johnson S, Gold MR, Baciu A. 2020. Rethinking the leading health indicators for healthy people 2030. JAMA Health Forum 1:5e200426
    [Google Scholar]
81. 81.

    Kajeepeta S, Mauro PM, Keyes KM, El-Sayed AM, Rutherford CG, Prins SJ. 2021. Association between county jail incarceration and cause-specific county mortality in the USA, 1987–2017: a retrospective, longitudinal study. Lancet Public Health 6:e240–48
    [Google Scholar]
82. 82.

    Kajstura A. 2018. States of women's incarceration: the global context 2018. Prison Polic. Initiative June. https://www.prisonpolicy.org/global/women/2018.html
    [Google Scholar]
83. 83.

    King C, Cook R, Giang LM, Bart G, Hoffman K, Waddell EN, Korthuis PT. 2022. Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam. J. Subst. Abuse Treat. 134:108451
    [Google Scholar]
84. 84.

    Kinner SA, Rich JD. 2018. Drug Use in Prisoners: Epidemiology, Implications, and Policy Responses Oxford, UK: Oxford Univ. Press
85. 85.

    Kirk DS, Wakefield S 2018. Collateral consequences of punishment: a critical review and path forward. Annu. Rev. Criminol. 1:171–94
    [Google Scholar]
86. 86.

    Krawczyk N, Mojtabai R, Stuart EA, Fingerhood MI, Agus D et al. 2021. Opioid agonist treatment is highly protective against overdose death among a US statewide population of justice-involved adults. Am. J. Drug Alcohol Abuse 47:117–26
    [Google Scholar]
87. 87.

    Krawczyk N, Picher CE, Feder KA, Saloner B. 2017. Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Aff. 36:2046–53
    [Google Scholar]
88. 88.

    Kwan A, Garcia-Grossman I, Sears D, Bertozzi SM, Williams B. 2022. The impact of COVID-19 on the health of incarcerated older adults in California state prisons. Health Aff. 41:1191–201
    [Google Scholar]
89. 89.

    Kwan A, Sears D, Bertozzi SM, Williams B. 2022. California state prisons during the COVID-19 pandemic Rep. CalPROTECT Proj. San Francisco:
90. 90.

    Lamb HR, Weinberger LE. 2005. The shift of psychiatric inpatient care from hospitals to jails and prisons. J. Am. Acad. Psychiatry Law 33:529–34
    [Google Scholar]
91. 91.

    Lambert LA, Armstrong LR, Lobato MN, Ho C, France AM, Haddad MB. 2016. Tuberculosis in jails and prisons: United States, 2002–2013. Am. J. Public Health 106:2231–37
    [Google Scholar]
92. 92.

    Laqueur H. 2015. Uses and abuses of drug decriminalization in Portugal. Law Soc. Inq. 40:746–81
    [Google Scholar]
93. 93.

    Marquez N, Ward JA, Parish K, Saloner B, Dolovich S. 2021. COVID-19 incidence and mortality in federal and state prisons compared with the US population, April 5, 2020, to April 3, 2021. JAMA 326:1865–67
    [Google Scholar]
94. 94.

    Maruschak LM, Berzofsky M, Unangst J. 2015. Medical problems of state and federal prisoners and jail inmates, 2011–12 NCJ 248491 US Dep. Justice, Off. Justice Programs, Bur. Justice https://bjs.ojp.gov/content/pub/pdf/mpsfpji1112.pdf
95. 95.

    Massoglia M. 2008. Incarceration as exposure: the prison, infectious disease, and other stress-related illnesses. J. Health Soc. Behav. 49:56–71
    [Google Scholar]
96. 96.

    Massoglia M, Pare P-P, Schnittker J, Gagnon A. 2014. The relationship between incarceration and premature adult mortality: gender specific evidence. Soc. Sci. Res. 46:142–54
    [Google Scholar]
97. 97.

    Massoglia M, Remster B. 2019. Linkages between incarceration and health. Public Health Rep. 134:8S–14
    [Google Scholar]
98. 98.

    Mathew P, Elting L, Cooksley C, Owen S, Lin J 2005. Cancer in an incarcerated population. Cancer 104:2197–204
    [Google Scholar]
99. 99.

    McNeil R, Fleming T, Mayer S, Barker A, Mansoor M et al. 2022. Implementation of safe supply alternatives during intersecting COVID-19 and overdose health emergencies in British Columbia, Canada, 2021. Am. J. Public Health 112:S151–58
    [Google Scholar]
100. 100.

     Merrall ELC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M et al. 2010. Meta-analysis of drug-related deaths soon after release from prison. Addiction 105:1545–54
     [Google Scholar]
101. 101.

     Mitchell A, Williams B. 2017. Compassionate release policy reform: physicians as advocates for human dignity. AMA J. Ethics 19:854–61
     [Google Scholar]
102. 102.

     Mitchell C. 2021. Lessons from the APHA policy statement on incarceration and public health: building sustained partnerships for systemic change Presented at the APHA 2001 Annual Meeting and Expo online, Oct 24–27
103. 103.

     Moazen B, Mauti J, Meireles P, Černíková T, Neuhann F et al. 2021. Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study. Harm Reduct. J. 18:14
     [Google Scholar]
104. 104.

     Nair S, McGreevy JE, Hutchinson-Colas J, Turock H, Chervenak F, Bachmann G. 2021. Pregnancy in incarcerated women: need for national legislation to standardize care. J. Perinat. Med. 49:830–36
     [Google Scholar]
105. 105.

     Netherland J, Kral AH, Ompad DC, Davis CS, Bluthenthal RN et al. 2022. Principles and metrics for evaluating Oregon's innovative drug decriminalization measure. J. Urban Health 99:328–31
     [Google Scholar]
106. 106.

     Nosrati E, Kang-Brown J, Ash M, McKee M, Marmot M, King LP. 2021. Incarceration and mortality in the United States. SSM—Popul. Health 15:100827
     [Google Scholar]
107. 107.

     Nowotny KM, Omori M, McKenna M, Kleinman J. 2020. Incarceration rates and incidence of sexually transmitted infections in US counties, 2011–2016. Am. J. Public Health 110:S130–36
     [Google Scholar]
108. 108.

     Pettit B. 2012. Invisible Men: Mass Incarceration and the Myth of Black Progress New York: Russell Sage Found.
109. 109.

     Pont J, Enggist S, Stöver H, Williams B, Greifinger R, Wolff H. 2018. Prison health care governance: guaranteeing clinical independence. Am. J. Public Health 108:472–76
     [Google Scholar]
110. 110.

     Pope L, Delany-Brumsey A. 2016. Creating a culture of safety: sentinel event reviews for suicide and self-harm in correctional facilities Rep. Vera Inst. Justice New York:
111. 111.

     Prins SJ. 2014. Prevalence of mental illnesses in US state prisons: a systematic review. Psychiatr. Serv. 65:862–72
     [Google Scholar]
112. 112.

     Prins SJ, Story B. 2020. Connecting the dots between mass incarceration, health inequity, and climate change. Am J. Public Health 110:S35–36
     [Google Scholar]
113. 113.

     Prost SG, Novisky MA, Rorvig L, Zaller N, Williams B. 2021. Prisons and COVID-19: a desperate call for gerontological expertise in correctional health care. Gerontologist 61:3–7
     [Google Scholar]
114. 114.

     Puglisi LB, Wang EA. 2021. Health care for people who are incarcerated. Nat. Rev. Dis. Primers 7:50
     [Google Scholar]
115. 115.

     Pullen-Blasnik H, Simes JT, Western B. 2021. The population prevalence of solitary confinement. Sci. Adv. 7:eabj1928
     [Google Scholar]
116. 116.

     Rego X, Oliveira MJ, Lameira C, Cruz OS. 2021. 20 years of Portuguese drug policy—developments, challenges and the quest for human rights. Subst. Abuse Treat. Prev. Polic. 16:59
     [Google Scholar]
117. 117.

     Roberson ML, McGee-Avila JK. 2021. Justice-involved women and cervical cancer disparities: issues of surveillance, education, and policy. J. Correct. Health Care 27:205–9
     [Google Scholar]
118. 118.

     Rorvig L, Williams B. 2021. Providing ethical and humane care to hospitalized, incarcerated patients with COVID-19. Am. J. Hosp. Palliat. Med. 38:731–33
     [Google Scholar]
119. 119.

     Ryckman T, Chin ET, Prince L, Leidner D, Long E et al. 2021. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health 6:e760–70
     [Google Scholar]
120. 120.

     Sander G, Shirley-Beavan S, Stone K. 2019. The global state of harm reduction in prisons. J. Correct. Health Care 25:105–20
     [Google Scholar]
121. 121.

     Santora L, Espnes GA, Lillefjell M. 2014. Health promotion and prison settings. Int. J. Prison. Health 10:27–37
     [Google Scholar]
122. 122.

     Sawyer W, Wagner P. 2022. Mass incarceration: the whole pie 2022. Prison Policy Initiative March 14. https://www.prisonpolicy.org/reports/pie2022.html
     [Google Scholar]
123. 123.

     Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. 2021. The impact of the opioid crisis on U.S. state prison systems. Health Justice 9:17
     [Google Scholar]
124. 124.

     Sears D, Ahalt C, Augustine D, Williams B 2020. Occupational health: a key to the control of COVID-19 in correctional facilities. Ann. Intern. Med. 173:924–25
     [Google Scholar]
125. 125.

     Sevelius J, Jenness V. 2017. Challenges and opportunities for gender-affirming healthcare for transgender women in prison. Int. J. Prison. Health 13:32–40
     [Google Scholar]
126. 126.

     Shannon SKS, Page J. 2014. Bureaucrats on the cell block: prison officers’ perceptions of work environment and attitudes toward prisoners. Soc. Serv. Rev. 88:630–57
     [Google Scholar]
127. 127.

     Sharma A, O'Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP 2016. Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst. Abuse Rehabil. 7:27–40
     [Google Scholar]
128. 128.

     Shavit S, Aminawung JA, Birnbaum N, Greenberg S, Berthold T et al. 2017. Transitions clinic network: challenges and lessons in primary care for people released from prison. Health Aff. 36:1006–15
     [Google Scholar]
129. 129.

     Simes JT, Jahn JL. 2022. The consequences of Medicaid expansion under the Affordable Care Act for police arrests. PLOS ONE 17:e0261512
     [Google Scholar]
130. 130.

     Skarha J, Peterson M, Rich JD, Dosa D. 2020. An overlooked crisis: extreme temperature exposures in incarceration settings. Am J. Public Health 110:S41–42
     [Google Scholar]
131. 131.

     Skarupski KA, Gross A, Schrack JA, Deal JA, Eber GB. 2018. The health of America's aging prison population. Epidemiol. Rev. 40:157–65
     [Google Scholar]
132. 132.

     Small W, McNeil R. 2018. Understanding the risk environment surrounding drug use in prisons: the unique contributions of qualitative research. See Ref. 84 161–74
133. 133.

     Smith PS, Ugelvik T, eds. 2017. Scandinavian Penal History, Culture and Prison Practice: Embraced by the Welfare State? London: Palgrave Macmillan
134. 134.

     Solomon L, Montague BT, Beckwith CG, Baillargeon J, Costa M et al. 2014. Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff. 33:434–42
     [Google Scholar]
135. 135.

     Stanley LL. 1919. Influenza at San Quentin prison, California. Public Health Rep. 34:996–1008
     [Google Scholar]
136. 136.

     Stone J, Fraser H, Lim AG, Walker JG, Ward Z et al. 2018. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect. Dis. 18:1397–409
     [Google Scholar]
137. 137.

     Sufrin C. 2021. Reproductive health care for incarcerated pregnant, postpartum, and nonpregnant individuals Comm. Opin. 830 Am. Coll. Obstet. Gynecol. Washington, DC: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/07/reproductive-health-care-for-incarcerated-pregnant-postpartum-and-nonpregnant-individuals
138. 138.

     Sugarman OK, Bachhuber MA, Wennerstrom A, Bruno T, Springgate BF. 2020. Interventions for incarcerated adults with opioid use disorder in the United States: a systematic review with a focus on social determinants of health. PLOS ONE 15:e0227968
     [Google Scholar]
139. 139.

     Sundaresh R, Yi Y, Harvey TD, Roy B, Riley C et al. 2021. Exposure to family member incarceration and adult well-being in the United States. JAMA Netw. Open 4:e2111821
     [Google Scholar]
140. 140.

     Sykes GM. 1958. The pains of imprisonment. The Society of Captives: Study of a Maximum Security Prison63–78. Princeton, NJ: Princeton Univ. Press
     [Google Scholar]
141. 141.

     Thakrar AP, Alexander GC, Saloner B. 2021. Trends in buprenorphine use in US jails and prisons from 2016 to 2021. JAMA Netw. Open 4:e2138807
     [Google Scholar]
142. 142.

     Thompson HA. 2010. Why mass incarceration matters: rethinking crisis, decline, and transformation in postwar American history. J. Am. Hist. 97:703–34
     [Google Scholar]
143. 143.

     Thompson HA. 2012. The prison industrial complex: A growth industry in a shrinking economy. New Labor Forum Aug. https://newlaborforum.cuny.edu/2012/08/06/the-prison-industrial-complex/
     [Google Scholar]
144. 144.

     Travis J, Western B, Redburn FS, Natl. Res. Counc 2014. The Growth of Incarceration in the United States: Exploring Causes and Consequences Washington, DC: Natl. Acad. Press
145. 145.

     Ugelvik T 2016. Prisons as welfare institutions? Punishment and the Nordic model. Handbook on Prisons Y Jewkes, J Bennett, B Crewe 388–402. London: Routledge
     [Google Scholar]
146. 146.

     UN Gen. Assem. Resolut. 70/175 2015. United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules) Dec. 17. UN Doc. A/RES/70/175. https://undocs.org/A/RES/70/175
147. 147.

     Van Hout MC, Kewley S, Hillis A. 2020. Contemporary transgender health experience and health situation in prisons: a scoping review of extant published literature (2000–2019). Int. J. Transgend. Health 21:258–306
     [Google Scholar]
148. 148.

     Wacquant L. 2010. Class, race & hyperincarceration in revanchist America. Daedalus 139:74–90
     [Google Scholar]
149. 149.

     Walker S, Lancaster K, Stoové M, Higgs P, Wilson M. 2018. “I lost me visits” a critical examination of prison drug policy and its effects on connection to family for incarcerated young men with histories of injecting drug use. Contemp. Drug Probl. 45:303–28
     [Google Scholar]
150. 150.

     Wang EA, Green J. 2010. Incarceration as a key variable in racial disparities of asthma prevalence. BMC Public Health 10:290
     [Google Scholar]
151. 151.

     Wang EA, Macmadu A, Rich JD. 2019. Examining the impact of criminal justice involvement on health through federally funded, national population-based surveys in the United States. Public Health Rep. 134:22S–33
     [Google Scholar]
152. 152.

     Wang EA, Pletcher M, Lin F, Vittinghoff E, Kertesz SG et al. 2009. Incarceration, incident hypertension, and access to health care: findings from the coronary artery risk development in young adults (CARDIA) study. Arch. Intern. Med. 169:687–93
     [Google Scholar]
153. 153.

     Wang EA, Western B, Berwick DM. 2020. COVID-19, decarceration, and the role of clinicians, health systems, and payers: a report from the National Academy of Sciences, Engineering, and Medicine. JAMA 324:2257–58
     [Google Scholar]
154. 154.

     Weidner RR, Schultz J. 2019. Examining the relationship between US incarceration rates and population health at the county level. SSM—Popul. Health 9:100466
     [Google Scholar]
155. 155.

     Wen H, Druss BG, Cummings JR. 2015. Effect of Medicaid expansions on health insurance coverage and access to care among low-income adults with behavioral health conditions. Health Serv. Res. 50:1787–809
     [Google Scholar]
156. 156.

     Wenger L, Showalter D, Wheeler E, Harris J, Binswanger I et al. 2019. A primer for implementation of overdose education and naloxone distribution in jails and prisons Rep. RTI Int. Durham, NC:
157. 157.

     WHO (World Health Organ.) 2022. Global HIV, hepatitis and STIs programmes: people in prisons and other closed settings. World Health Organization https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/populations/people-in-prisons
     [Google Scholar]
158. 158.

     Wildeman C. 2016. Incarceration and population health in wealthy democracies. Criminology 54:360–82
     [Google Scholar]
159. 159.

     Wildeman C, Muller C. 2012. Mass imprisonment and inequality in health and family life. Annu. Rev. Law Soc. Sci. 8:11–30
     [Google Scholar]
160. 160.

     Wildeman C, Wang EA. 2017. Mass incarceration, public health, and widening inequality in the USA. Lancet 389:1464–74
     [Google Scholar]
161. 161.

     Williams BA, Li A, Ahalt C, Coxson P, Kahn JG, Bibbins-Domingo K. 2019. The cardiovascular health burdens of solitary confinement. J. Gen. Intern. Med. 34:1977–80
     [Google Scholar]
162. 162.

     Wilper AP, Woolhandler S, Boyd JW, Lasser KE, McCormick D et al. 2009. The health and health care of US prisoners: results of a nationwide survey. Am. J. Public Health 99:666–72
     [Google Scholar]
163. 163.

     Zaller ND, Cloud DH, Brinkley-Rubinstein L, Martino S, Bouvier B, Brockmann B. 2017. Commentary: The importance of Medicaid expansion for criminal justice populations in the south. Health Justice 5:2
     [Google Scholar]
164. 164.

     Zhong S, Senior M, Yu R, Perry A, Hawton K et al. 2021. Risk factors for suicide in prisons: a systematic review and meta-analysis. Lancet Public Health 6:e164–74
     [Google Scholar]
165. 165.

     Zucker H, Annucci AJ, Stancliff S, Catania H. 2015. Overdose prevention for prisoners in New York: a novel program and collaboration. Harm Reduct. J. 12:51
     [Google Scholar]
166. 166.

     Zust BL. 2009. Partner violence, depression, and recidivism: the case of incarcerated women and why we need programs designed for them. Issues Ment. Health Nurs. 30:246–51
     [Google Scholar]